Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.

Author: Doushakar Zulujas
Country: Malaysia
Language: English (Spanish)
Genre: Personal Growth
Published (Last): 25 October 2005
Pages: 66
PDF File Size: 12.84 Mb
ePub File Size: 8.75 Mb
ISBN: 524-3-77966-787-6
Downloads: 44203
Price: Free* [*Free Regsitration Required]
Uploader: Nikoran

CiteScore measures average citations received per document published. March Pages ee24 Pages Subscriber If you already have your login data, please click here.

Three patients received low molecular weight heparin prior to using rTPA. The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters.

Previous article Next article.

Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos

The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in ativador of them. Nine issues are published each year, including mostly originals, reviews and consensus documents.


The Impact Factor measures the average number of citations received in a particular year by papers published in the activadod during the two receding years. They received between 1 to 5 cycles with rTPA.

The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days. Subscribe to our Newsletter. This item has received.

Si continua navegando, consideramos que acepta su uso.

Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns. Print Send to a friend Export reference Mendeley Statistics.

Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator.

There was a problem providing the content you requested

To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. There were no deaths or embolism. Continuing navigation will be considered as acceptance of this use. The aim of this study is to describe the response and complications related to the use sel rTPA in the management of life- threatening cardiac thrombi rel newborns.

SRJ is a prestige metric based on the idea that not all citations are the same. Are you a health professional able to prescribe or dispense drugs? Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative plasminoveno heparin in life threatening giant thrombus and embolization. In 4 patients complete resolution of the thrombus was achieved in a mean of 3.


You can change the settings or obtain more information by clicking here.

SJR uses a similar algorithm activwdor the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Four patients had intracranial haemorrhage grade I, without sequelae at follow-up.

From Monday to Friday from 9 a. The patients included 4 males with a mean weight of gr.